San Francisco-based Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Founded by Melanie Matheu and Noelle Mullin in 2016, Prellis Biologics is backed by investors that include Cantos, IndieBio, Plug and Play, SOSV, and True Ventures.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Melanie Matheu, Noelle Mullin
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
